Michael P. Murphy, MD

Bio

Dr. Michael Murphy is a vascular surgeon in Indianapolis, Indiana and is affiliated with multiple hospitals in the area, including Eskenazi Health-Indianapolis and Indiana University Health Medical Center. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice for more than 20 years. He is one of 6 doctors at Eskenazi Health-Indianapolis and one of 7 at Indiana University Health Medical Center who specialize in Vascular Surgery.

Medical Education:

1989   Columbia University, New York, NY

Surgical Training:

1993   Research Fellow, Harvard Medical School, Cardiac Surgery and HeartFailure, Boston,MA

1996   General Surgery Residency, Brigham and Women's Hospital, Harvard Medical School,  Boston, MA

1996   Chief Resident, General Surgery, Brigham and Women's Hospital, Harvard Medical School,  Boston, MA

1997   Assistant to the Surgeon-in-Chief, General Surgery,Brigham and Women's Hospital, Harvard Medical School,  Boston, MA

2003   Vascular Surgery Fellowship, Duke University, Durham, NC

Key Publications

Murphy MP, Dalsing MC, Lawson JH, Shafique SS, Klein JH, McKale JM, Abonour RF,Hutchins GD, March KL. Autologous Bone Marrow Mononuclear Cell Therapy is Safe and Promotes Amputation Free Survival in Patients with Critical Limb Ischemia J Vasc Surg 2011; 53: 1565-74.

Sharma AK, Lu G, Jester A, Johnston W, Zhao Y, Hajzus V, Saadatzadeh MR, Su G, Bhamidipati CM, Mehta G, Kron IL, Laubach VE, Murphy MP, and Upchurch GR. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation 2012;126: S38-S45.

Prasain, N., Lee, M.R., Vemula, S., Meador, J. L., Yoshimoto, M.,  Ferkowicz, M.K., Fett, A., Gupta, M., Rapp, B.M., Saadatzadeh,   M.R., Ginsberg, M., Elemento, O., Lee, Y., Murphy, M.P., Voytik-Harbin, S.L., Rafii, S., Broxmeyer, H.E., Yoder, M.C., Novel protocol to derive endothelial colony forming cells that display high clonal proliferative potential, extensive replicative capacity, and in vivo vessel forming potential from human pluripotent stem cells. Nat Biotechnol. 2014 Nov; 32(11):1151-7.

Xie J, Jones TJ, Feng D, Cook TG, Jester AA, Babbey CM, March KL, Murphy MP. Human Adipose-Derived Stem Cells Suppress Elastase-induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion through Paracrine Factors. Cell Transplant. 2017 Feb 16;26(2):173-189.

Perin EC, Murphy MP, March KL, et. Al.Cardiovascular Cell Therapy Research Network (CCTRN). Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN Patients with Intermittent Claudication Injected with ALDH Bright Cells (PACE) Trial. Circulation. 2017 Feb 16.

Murphy MP. Ross CR, Kibbe MR. Kelso RL,Sharafuddin MJ, Zeng E, Velazquez O,Laird J, MD and the MOBILE Trial Working Group. A Randomized Evaluation of Autologous Bone Marrow Cell Therapy for Critical Limb Ischemia:  Results of the Phase III MOBILE Trial.